8-KThe WireRoutine
Reg FD Disclosure
Filed Jun 17, 2026 · 13d ago · Accession 0001193125-26-273405
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Avalyn Pharma Inc.
- Ticker
- AVLN
- CIK
- 1540171
- Form type
- 8-K
- Filing date
- Jun 17, 2026
- Report date
- Jun 17, 2026
- Document
- ck0001540171-20260617.htm
- Size
- 179 KB